| | | | | | | | | | |
|
|
| Dockets Entered
On May 19, 2005
Table of Contents
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
| 1977N-0317
|
| TETRACYCLINE, PROPOSAL TO REVISE REGULATIONS
|
|
|
| 1990S-0308
|
| Generic Drug Speeches & Policy and Procedure Guides
|
|
|
| 2002D-0389
|
| Nonclinical Studies for Development of Pharmaceutical Excipi
|
|
|
| 2002N-0277
|
| Bioterrorism; Establishment & Maintenance of Records
|
|
|
| 2003D-0263
|
| Draft Guidance for Industry: Channels of Trade Policy for Commodities With Residues of Pesticide Chemicals, for Which Tolerances Have Been Revoked, Suspended, or Modified by the Environmental Protecti
|
|
|
|
|
|
| 2004E-0316
|
| Patent Extension for ERTACZO (sertaconazole nitrate), U.S. Patent No. 5,135,943
|
|
|
| 2004H-0322
|
| Civil Money Penalty Re: Ecumed Health Group, Inc.
|
|
|
| 2004N-0463
|
| Food Labeling: Prominence of Calories
|
|
|
| 2004N-0498
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Medical Devices; Device Tracking
|
|
|
| 2004N-0525
|
| Agency Information Collection Activities: Proposed Collection; Comment Request;
|
|
|
| 2004N-0564
|
| Agency Information Collection Activities; Proposed Collection;
|
|
|
| 2004P-0294
|
| Health Claim Petition: Noncariogenicity Dental Health Claim for Sucralose
|
|
|
| 2005D-0021
|
| International Conference on Harmonisation; Draft Guidance on Q8 Pharmaceutical Development
|
|
|
| 2005N-0045
|
| Agency Information Collection Activities: Proposed Collection; Comment Request; Electronic Records; Electronic Signatures
|
|
|
| 2005N-0137
|
| Levothyroxine Sodium Therapeutic Equivalence; Notice of Public Meeting
|
|
|
| 2005V-0198
|
| Projector for a Laser Light Show
|
|
|
| 1977N-0317
|
| TETRACYCLINE, PROPOSAL TO REVISE REGULATIONS
|
|
|
| ANS 90
|
| HFW-1 to Hon. Ike Andrews
|
| Vol #:
|
| 2
|
|
|
| 1990S-0308
|
| Generic Drug Speeches & Policy and Procedure Guides
|
|
|
| M
754
|
| Statistical Report - Month of April 2005
|
| Vol #:
|
| 54
|
|
|
| 2002D-0389
|
| Nonclinical Studies for Development of Pharmaceutical Excipi
|
|
|
| GDL
2
|
| Guideline
|
| Vol #:
|
| 1
|
|
|
| NAD
2
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2002N-0277
|
| Bioterrorism; Establishment & Maintenance of Records
|
|
|
| NM
3
|
| FDA
|
| Vol #:
|
| 16
|
|
|
| 2003D-0263
|
| Draft Guidance for Industry: Channels of Trade Policy for Commodities With Residues of Pesticide Chemicals, for Which Tolerances Have Been Revoked, Suspended, or Modified by the Environmental Protecti
|
|
|
|
|
|
|
| GDL
2
|
| Guideline
|
| Vol #:
|
| 1
|
|
|
| NAD
2
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| SS
1
|
| Supporting Statement
|
| Vol #:
|
| 1
|
|
|
| 2004E-0316
|
| Patent Extension for ERTACZO (sertaconazole nitrate), U.S. Patent No. 5,135,943
|
|
|
| N
1
|
| FDA
|
| Vol #:
|
| 1
|
|
| | | | | | | | |
|
|
| 2004H-0322
|
| Civil Money Penalty Re: Ecumed Health Group, Inc.
|
|
|
| CS
7
|
| HFA-305
|
| Vol #:
|
| 1
|
|
|
| OR 7
|
| HF-3 to Ecumed Health Group, Amador Reyes, Juan C. Carrrai, Richard W. Stone, M.D., Erlinda E.
|
| Vol #:
|
| 1
|
|
|
| 2004N-0463
|
| Food Labeling: Prominence of Calories
|
|
|
| C 29
|
| L. Best
|
| Vol #:
|
| 1
|
|
|
| C 30
|
| Ms. M. Van Egmond
|
| Vol #:
|
| 1
|
|
|
| C 31
|
| J. Samter
|
| Vol #:
|
| 1
|
|
|
| EMC 279
|
| C. Hoffman
|
| Vol #:
|
| 3
|
|
|
| EMC 280
|
| K. Janes
|
| Vol #:
|
| 3
|
|
|
| 2004N-0498
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Medical Devices; Device Tracking
|
|
|
| NAL
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| SS
1
|
| Supporting Statement
|
| Vol #:
|
| 1
|
|
|
| 2004N-0525
|
| Agency Information Collection Activities: Proposed Collection; Comment Request;
|
|
|
| NAL
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| SS
1
|
| Supporting Statement
|
| Vol #:
|
| 1
|
|
|
| 2004N-0564
|
| Agency Information Collection Activities; Proposed Collection;
|
|
|
| NCR
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2004P-0294
|
| Health Claim Petition: Noncariogenicity Dental Health Claim for Sucralose
|
|
|
| BKG 1
|
| BACKGROUND
|
| Vol #:
|
| 2
|
|
|
| NPR
1
|
| FDA
|
| Vol #:
|
| 2
|
|
|
| 2005D-0021
|
| International Conference on Harmonisation; Draft Guidance on Q8 Pharmaceutical Development
|
|
|
| NEC
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2005N-0045
|
| Agency Information Collection Activities: Proposed Collection; Comment Request; Electronic Records; Electronic Signatures
|
|
|
| N
3
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2005N-0137
|
| Levothyroxine Sodium Therapeutic Equivalence; Notice of Public Meeting
|
|
|
| LST
1
|
| Agenda for May 23, 2005 Meeting
|
| Vol #:
|
| 1
|
|
|
| 2005V-0198
|
| Projector for a Laser Light Show
|
|
|
| ACK
1
|
| Sapphire Night Club
|
| Vol #:
|
| 1
|
|
|
| VAR
1
|
| Sapphire
Night Club
|
| Vol #:
|
| 1
|
|